US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
オーストラリア
ASX
Osteopore Limited (OSX) 銘柄情報

Osteopore Limited (OSX)

0.006

0.00

(0.00%)

終了 6月9日 3:00PM

Osteopore Limited (OSX) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

0.006

( - )

買値

0.005

売値

0.006

出来高

13,948,272

0.0055 日の範囲 0.006

0.005 52 週間の範囲 0.029

時価総額

前日終値

0.006

始値

0.006

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

AUD 4,469,866

発行済株式数

626,358,066

配当利回り

PER

-0.3

1 株当たり利益 (EPS)

-0.02

歳入

3.06M

純利益

-3.72M

Osteopore Limited, a regenerative medicine company, engages in the production of 3D-printed biomimetic and bioresorbable implants in Vietnam, South Korea, the Philippines, Singapore, India, Taiwan, Indonesia, the Netherlands, the United Arab Emirates, Australia, and internationally. The company comm... Osteopore Limited, a regenerative medicine company, engages in the production of 3D-printed biomimetic and bioresorbable implants in Vietnam, South Korea, the Philippines, Singapore, India, Taiwan, Indonesia, the Netherlands, the United Arab Emirates, Australia, and internationally. The company commercializes products designed to enable natural bone healing across multiple therapeutic areas. Its technology fabricates specific micro-structured scaffolds for bone regeneration through 3D printing and bioresorbable material. It manufactures and trades medical implants and medical devices; and provides technology services, as well as engages in research and experimental development on biotechnology and medical science. Osteopore Limited was founded in 2003 and is headquartered in Singapore. 詳細を表示

セクター

Healthcare

業界

Medical Equipment & Supplies

ウェブサイト

www.osteopore.com

本社

Singapore, Singapore

設立

2026

Osteopore Limited is listed in the Healthcare sector of the オーストラリア証券取引所 with ticker OSX. The last closing price for Osteopore was AUD0.01. Over the last year, Osteopore shares have traded in a share price range of AUD 0.005 to AUD 0.029.

Osteopore currently has 626,358,066 shares in issue. The market capitalisation of Osteopore is AUD3.76 million. Osteopore has a price to earnings ratio (PE ratio) of -0.30.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0.006	0.0065	0.0055	1466733	0.006	DE
4	-0.001	-14.2857142857	0.007	0.01	0.0055	6886334	0.00681207	DE
12	-0.001	-14.2857142857	0.007	0.01	0.005	4182428	0.00664524	DE
26	-0.002	-25	0.008	0.029	0.005	7966242	0.01210753	DE
52	-0.007	-53.8461538462	0.013	0.029	0.005	5156090	0.01200619	DE
156	-0.08	-93.023255814	0.086	0.755	0.005	2540443	0.02492343	DE
260	-0.439	-98.6516853933	0.445	0.755	0.005	1546406	0.03007787	DE

OSX - Frequently Asked Questions (FAQ)

What is the current Osteopore Limited share price?

The current share price of Osteopore Limited is AUD 0.006

How many Osteopore Limited shares are in issue?

Osteopore Limited has 626,358,066 shares in issue

What is the market cap of Osteopore Limited?

The market capitalisation of Osteopore Limited is AUD 3.76M

What is the 1 year trading range for Osteopore Limited share price?

Osteopore Limited has traded in the range of AUD 0.005 to AUD 0.029 during the past year

What is the PE ratio of Osteopore Limited?

The price to earnings ratio of Osteopore Limited is -0.3

What is the cash to sales ratio of Osteopore Limited?

The cash to sales ratio of Osteopore Limited is 1.23

What is the registered address of Osteopore Limited?

The registered address for Osteopore Limited is 2 Tukang Innovation Grove #09-06/07, Singapore, 618305

What is the Osteopore Limited website address?

The website address for Osteopore Limited is www.osteopore.com

Which industry sector does Osteopore Limited operate in?

Osteopore Limited operates in the Medical Equipment & Supplies sector

Galzus Research

Galzus Research 3分前

I believe my point has been very explicit.

The idea that keeps getting raised here is that DCVax, some version of it, has a shot at tissue-agnostic approval. And that this might even be a plausible reason for the "delay" with the MHRA.

The point I keep raising is that

ollik78

ollik78 6分前

CHAI 10+ 🚬📈🧐

brazen22

brazen22 7分前

I think calling leukapheresis capacity and adding Dr. Jenkins “ongoing operations” minimizes the point.

If they were merely ordinary business items, why PR them at all?

The obvious reason is that NWBO wanted investors to understand operational readiness and progress tow

Z06 MAN

Z06 MAN 10分前

What happened to the 10 ton goal for May? Just another false statement. They haven’t produced enough for the 1.5 tons of finished product. At this rate, the end of 2026 might see sales. More Patience required….

i_like_bb_stock

i_like_bb_stock 11分前

$BTOG wow RW filing they usually move on this
https://www.sec.gov/Archives/edgar/data/1735556/000110465926071537/tm2522888d5_rw.htm

i_like_bb_stock

i_like_bb_stock 11分前

$BTOG wow RW filing they usually move on this
https://www.sec.gov/Archives/edgar/data/1735556/000110465926071537/tm2522888d5_rw.htm

abrooklyn

abrooklyn 12分前

https://medium.com/codetech/tell-me-more-about-core-tmmac-becomes-an-official-core-community-education-channel-b825e9b8e2a6

Buckey

Buckey 12分前

More pure insanity Premarket some on no news

also add in stocks just mentioning AI

we are in a bubble. The hype is overwhelming on AI SpaceEx etc. Been there done that.

funnytimes2

funnytimes2 13分前

Kraig Biocraft Laboratories Sets New All-Time Production Record, Delivering Nearly 2.5 Metric Tons of Recombinant Spider Silk in Single Production Cycle

Company Continues Delivering on Aggressive 2026 Expansion Strategy as Production Scale Reaches New Heights

ANN ARBOR,

AMOTE1

AMOTE1 14分前

“We said 2026 would be a year of aggressive expansion and accelerating production, and our team continues to execute on that commitment,” said Kim Thompson, CEO and Founder of Kraig Labs. “Nearly 2.5 metric tons from a single production cycle is a first for industry and a world record. Each producti

John Doe 2024

John Doe 2024 14分前

Taking a toxic loan from Auctus and giving it to XTI and diluting hundreds of millions of shares to pay it back is why pps is a measly 2 cents not because of manipulation!

Madguppy

Madguppy 18分前

May be a post to check out in the short term.

https://x.com/scottmi65383320/status/2064163222131995113?s=20

Monksdream

Monksdream 18分前

TOP 15
https://www.advfn.com/markets/nasdaq/premarket

RIGATONI

RIGATONI 20分前

Dip here into the .27s, may be a nice buy-back area ~Rig

AMOTE1

AMOTE1 20分前

https://www.kraiglabs.com/kraig-biocraft-laboratories-sets-new-all-time-production-record-delivering-nearly-2-5-metric-tons-of-recombinant-spider-silk-in-single-production-cycle/

Jake731

Jake731 21分前

Good morning all.

TPTW-EM……!!!!!!!

VuMe Live 😎😎😎

jopo

Seem's, Webull is working good for you.

RIGATONI

RIGATONI 22分前

Good morning! ~Rig

jimmybob

jimmybob 23分前

$RDDT with some pre-market love

US Market News

US Market News 24分前

Fresh Del Monte Produce Inc. Announces Name Change to Del Monte Corporation and NYSE Ticker Symbol Change to “DMC”June 9, 2026 6:30 AM
Business Wire Reflects the Company's Expanded Role as Global Owner of the Del Monte® Brand; Ticker Symbol Change Effective Jun

US Market News

US Market News 25分前

Four-Year BIOMAG™-I Study Results Presented at EuroPCR Confirm Long-Term Safety and Sustained Performance of the Freesolve™ Resorbable Magnesium Scaffold (DREAMS 3G)June 9, 2026 6:30 AM
Business Wire Persistently Low Target Lesion Failure and No New Cardiac-Rel

US Market News

US Market News 25分前

Uxin to Report First Quarter 2026 Financial Results on June 16, 2026June 9, 2026 6:30 AM
PR Newswire (US) class="legendSpanClass"BEIJING, class="legendSpanClass"June 9, 2026 /PRNewswire/ -- Uxin Limited ("Uxin" or the "Company") (Nasdaq:

SovereignNinja5

SovereignNinja5 25分前

Vascepa still holds roughly 50% of the total icosapent ethyl market even with zero sales reps on the ground and after losing preferred status at CVS. That’s not a dead product — that’s a product that’s been surviving on brand loyalty and prescriber habit while the company was busy firing its commerc

US Market News

US Market News 25分前

Trilogy Metals Announces Commencement of 2026 Summer Field Program at the Upper Kobuk Mineral Projects in AlaskaJune 9, 2026 6:30 AM
PR Newswire (US) class="legendSpanClass"VANCOUVER, BC, class="legendSpanClass"June 9, 2026 /PRNewswire/

Mitsui Fudosan (PK)

1.75% Coupon Until 16jan...

Floating Rate Sub Cap De...

Pliant Therapeutics

Wrst Fxd Cpn Atcl Nts Lk...

Vontobel Financial Produ...

Many Peaks Minerals

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。